Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer

Neoadjuvant chemotherapy has practical and theoretical advantages over adjuvant chemotherapy strategy in breast cancer (BC) management. Moreover, metronomic delivery has a more favorable toxicity profile. The present study examined the feasibility of neoadjuvant metronomic chemotherapy in two cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Petry, V., Gagliato, D.M., Leal, A.I.C., Arai, R.J., Longo, E., Andrade, F., Ricci, M.D., Piato, J.R., Barroso-Sousa, R., Hoff, P.M., Mano, M.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2015
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445673/
https://www.ncbi.nlm.nih.gov/pubmed/25760024
http://dx.doi.org/10.1590/1414-431X20144354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445673/
https://www.ncbi.nlm.nih.gov/pubmed/25760024
http://dx.doi.org/10.1590/1414-431X20144354

Ejemplares similares